| Financial Year |
March 31 2023 |
| Monetary Funds |
1,121,481,425.72 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,624,383,719.63 |
| Advances to Suppliers |
273,626,667.95 |
| Other Receivables |
24,338,849.44 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,315,908,692.97 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
417,043,483.76 |
| Total Current Assets |
6,971,094,501.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
672,149,928.71 |
| Long-term Equity Investment |
28,307,458.16 |
| Investment Properties |
4,323,293.94 |
| Fixed Assetes |
7,472,774,049.08 |
| Under-construction Projects |
1,349,530,176.04 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
614,276,534.48 |
| R&D expenses |
-- |
| Goodwill |
36,262,380.99 |
| Long-Term Deferred and Prepaid Expenses |
6,125,784.33 |
| Deferred Income Tax Assets |
91,713,572.39 |
| Other Non-Current Assets |
245,427,285.14 |
| Sub-Total of Non-Current Assets |
10,543,243,949.38 |
| Total Assets |
17,514,338,451.13 |
| Short-Term Loans |
2,838,432,688.19 |
| Trading Financial liabilities |
-- |
| Notes Payable |
201,868,939.29 |
| Accounts Payable |
1,667,658,702.77 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
94,770,305.26 |
| Taxes Payable |
126,989,937.73 |
| Interest Payable |
-- |
| Dividend Payable |
3,649,191.95 |
| Other payables |
269,265,915.25 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,194,394,288.07 |
| Other Current Liabilities |
18,203,457.33 |
| Sub-Total of Current Liabilities |
6,596,213,582.05 |
| Long-term Loans |
608,814,759.84 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
13,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
101,981,898.55 |
| Other Non-Current Liabilities |
1,880,965.32 |
| Sub-Total of Non-Current Liabilities |
901,513,884.19 |
| Total Liabilities |
7,497,727,466.24 |
| Paid-In Capital(Or Share Stock) |
868,968,879.00 |
| Capital Surplus |
2,398,142,315.17 |
| Surplus Reserve |
495,986,180.73 |
| LESS:Treasury Stock |
191,942,203.72 |
| Undistributed Profits |
6,527,468,646.15 |
| Minority Stockholder's Interest |
382,016,464.81 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,634,594,520.08 |
| Owner's Equity（Stockholder's Equity） |
10,016,610,984.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,514,338,451.13 |
